CircMED27

ncRNA information

ncRNA name

CircMED27

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Hepatocellular Carcinoma

Cancer site

qRT-PCR,Western blot

Treatment information

Treatment type

Chemotherapy

Drug

Lenvatinib

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma

Tissue resource

Clinical tissue samples and healthy donor samples

hepatocellular carcinoma cell lines Hep3B

hepatocellular carcinoma cell lines Huh7

hepatocellular carcinoma cell lines HepG2

hepatocellular carcinoma cell lines SK-Hep-1

hepatocellular carcinoma cell lines PLC/PRF/5

Experiment

None


Institute

Shanghai Cancer Center,Fudan University

the Chinese Academy of Science Cell Bank

Country

China

China

Continent

Asia

Asia

Asia

Asia

Asia

Asia